Pfizer: all 4,072 studies
Page 40 of 41. Open to participants first (153), then studies with results posted, then the rest; newest registration first within each.
- Study Evaluating DVS-233 SR And Venlafaxine ER In Adult Outpatients With Major Depressive DisorderCompletedNCT00090649Phase 3
- A Study Of The Safety And Efficacy Of AG-013,958 In Subjects With Subfoveal Choroidal Neovascularization Associated With Age-Related Macular DegenerationTerminatedNCT00090532Phase 1/2
- Study Evaluating MST-997 in Advanced Malignant Solid TumorsTerminatedNCT00088647Phase 1
- Study Evaluating DVS-233 SR and Venlafaxine ER in Adult Outpatients With Major Depressive DisorderCompletedNCT00087737Phase 3
- Intravenous Edotecarin in Patients With Advanced Gastric Cancer That Has Progressed or Recurred After ChemotherapyCompletedNCT00087503Phase 2
- FDG-PET to Investigate SGN-15 and Docetaxel in Patients With Advanced Non-Small Cell Lung CarcinomaCompletedNCT00086333Phase 2
- A Study of ARRY-142886 in Patients With Advanced CancerCompletedNCT00085787Phase 1
- Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine For The Treatment Of Uncomplicated, Symptomatic Falciparum Malaria In Southeast AsiaTerminatedNCT00084240Phase 2/3
- Azithromycin Plus Chloroquine Versus Atovaquone-Proguanil For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria In South AmericaCompletedNCT00084227Phase 2/3
- Study Evaluating CCI-779 and Letrozole in Post-menopausal Women With Breast CancerTerminatedNCT00083993Phase 3
- Azithromycin Plus Chloroquine Versus Mefloquine for the Treatment of Uncomplicated Malaria in AfricaCompletedNCT00082576Phase 2/3
- Azithromycin in Combination With Chloroquine Versus Chloroquine in the Eradication of Asymptomatic Plasmodium FalciparumTerminatedNCT00082563Phase 2
- Study Comparing Tigecycline to Imipenem/Cilastatin in Complicated Intra-Abdominal Infections in Hospitalized SubjectsCompletedNCT00081744Phase 3
- Study Comparing Tigecycline vs. Levofloxacin in Subjects Hospitalized With Community-Acquired PneumoniaCompletedNCT00081575Phase 3
- Study Evaluating Tigecycline Versus Imipenem/Cilastatin in Hospital-Acquired PneumoniaCompletedNCT00080496Phase 3
- Study Evaluating Tigecycline in Selected Serious Infections Due to Resistant Gram-Negative OrganismsCompletedNCT00079989Phase 3
- Study Evaluating Tigecycline in Selected Serious Infections Caused by Vancomycin-Resistant Enterococcus (VRE) or Methicillin-Resistant Staphylococcus Aureus (MRSA)CompletedNCT00079976Phase 3
- Study Evaluating Tigecycline vs Levofloxacin in Hospitalized With Community-Acquired PneumoniaCompletedNCT00079885Phase 3
- Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent Anaplastic Large Cell LymphomaCompletedNCT00079755Phase 2
- Study of SGN-40 in Patients With Refractory or Recurrent Multiple MyelomaCompletedNCT00079716Phase 1
- Study of the GARFT Inhibitor AG2037 in Patients With Metastatic Colorectal Cancer Who Failed TreatmentCompletedNCT00078468Phase 2
- A Study of SU11248 In Patients With Metastatic Breast Cancer Who Have Failed Selected Other Therapies.CompletedNCT00078000Phase 2
- Assessment Of Safety And Efficacy Of SU11248 In Patients With Metastatic Colorectal Cancer Who Have Failed Selected Previous Treatments.CompletedNCT00077987Phase 2
- Study Evaluating CCI-779 in Active Rheumatoid Arthritis on Concomitant Methotrexate TherapyTerminatedNCT00076206Phase 2
- Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive DisorderCompletedNCT00075257Phase 3
- Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 To Treat Small-Volume Ovarian, Peritoneal, Fallopian Tube CancerCompletedNCT00074867Phase 2
- A Clinical Efficacy Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 Given In Combination With ChemotherapyCompletedNCT00074854Phase 1/2
- Trial of Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine for the Treatment of Uncomplicated Malaria in IndiaCompletedNCT00074841Phase 2/3
- Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive DisorderCompletedNCT00073762Phase 3
- A Study to Evaluate the Efficacy and Safety of CP-101,606 in Subjects With an Acute StrokeTerminatedNCT00073476Phase 2
- Study Evaluating EAA-090 in Adult Outpatients With Neuropathic Pain Associated With Diabetic NeuropathyTerminatedNCT00073034Phase 2
- Irinotecan in Patients With Advanced Metastatic Breast Cancer Who Have Experienced Failure of an Anthracycline, a Taxane, and CapecitabineCompletedNCT00072852Phase 2
- Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive DisorderCompletedNCT00072774Phase 3
- Study Evaluating EKB-569 in Advanced Colorectal CancerCompletedNCT00072748Phase 2
- CPG 7909 Injection in MelanomaCompletedNCT00070642Phase 2
- CPG 7909 Injection in Non-Small Cell Lung CancerCompletedNCT00070629Phase 2
- Study of IV Edotecarin Vs Temozolomide or Carmustine (BCNU) or Lomustine (CCNU) in Patients With Glioblastoma MultiformeCompletedNCT00068952Phase 3
- A Study To Compare The Efficacy And Safety Of Pegvisomant To That Of Sandostatin Lar Depot In Patients With AcromegalyCompletedNCT00068042Phase 4
- Pegvisomant And Sandostatin LAR Combination StudyCompletedNCT00068029Phase 4
- Study Evaluating EKB-569 in Advanced Non-Small Cell Lung CancerCompletedNCT00067548Phase 2
- Study in Women With Metastatic Breast Cancer Whose Cancer Has Gotten Worse After Anthracycline and Taxane TherapyCompletedNCT00067314Phase 2
- Study Evaluating the Safety and Efficacy of Etanercept in Patients With Idiopathic Pulmonary FibrosisCompletedNCT00063869Phase 2
- Study Evaluating MAC-321 in Colorectal CancerCompletedNCT00063427Phase 2
- Study Evaluating MAC-321 in Non-small Cell Lung Cancer Refractory to Platinum-based TherapyCompletedNCT00063219Phase 2
- Study Evaluating DVS-233 in Adult Outpatients With Major Depressive DisorderCompletedNCT00063206Phase 3
- A Study to Determine if Antibiotics Prevent Infection in the Pancreas of Patients Where Part of the Pancreas Has DiedCompletedNCT00061438Phase 4
- Study Evaluating Sumanirole for the Treatment of the Signs and Symptoms of Early Parkinson's DiseaseCompletedNCT00058838Phase 3
- Treatment With SU11248 in Patients With Neuroendocrine TumorsCompletedNCT00056693Phase 2
- Safety, Tolerance and Pharmacokinetics of Anidulafungin in Immunocompromised Children Ages 2-17CompletedNCT00056381Phase 1/2
- The Safety and Efficacy of Anidulafungin Versus Comparator in Patients With Candidemia and Invasive CandidiasisCompletedNCT00056368Phase 3
- Study of the Safety and Efficacy of SU-011,248 in Adult Patients With Advanced Kidney CancerCompletedNCT00054886Phase 2
- Four-Drug Combination Treatment in Hiv-Infected Subjects Failing Therapy With Antiretroviral RegimensCompletedNCT00052117Phase 2
- Capravirine (AG1549) in Combination With Viracept and Two NRTIs in HIV Infected Patients Who Failed an Initial NNRTI Containing RegimenCompletedNCT00051844Phase 2
- A Safety/Efficacy Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent CD30+ Hematologic MalignanciesCompletedNCT00051597Phase 1/2
- Safety/Efficacy Study of SGN-15 (Antibody-Drug Conjugate) Combined With Gemcitabine in Patients With Ovarian CancerTerminatedNCT00051584Phase 2
- Safety/Efficacy Study of Immunoconjugate With Docetaxel in Non-small Cell Lung CarcinomaCompletedNCT00051571Phase 2
- A Phase II Study of CI-1033 in Treating Patients With Metastatic (Stage IV) Breast CancerCompletedNCT00051051Phase 2
- A Phase 2, Randomized, Open-Label Study Of Single Agent CI-1033 In Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00050830Phase 2
- Ventilator-Associated Pneumonia/Hospital-Acquired Pneumonia Requiring Mechanical Ventilatory SupportCompletedNCT00050401Phase 3
- Study Evaluating Venlafaxine ER in Recurrent DepressionCompletedNCT00046020Phase 4
- Study Evaluating Zosyn in Hospitalized Patients With Intra-abdominal InfectionCompletedNCT00044928Phase 4
- Study Evaluating Venlafaxine ER in Patients With Panic DisorderCompletedNCT00044772Phase 3
- Study Comparing the Safety and Efficacy of Piperacillin/Tazobactam to Cefepime in Patients With Hematologic Malignancy or LymphomaCompletedNCT00044759Phase 3
- Study Evaluating the Safety and Efficacy of Piperacillin/Tazobactam and Ampicillin/Sulbactam in Patients With Diabetic Foot InfectionsCompletedNCT00044746Phase 4
- Study Evaluating Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia After Stem Cell TransplantCompletedNCT00044733Phase 2
- Study Evaluating Sirolimus in End Stage Renal Disease in High Risk Kidney Transplant RecipientsCompletedNCT00044720Phase 4
- Treatment of Pediatric Hypertension With Altace TrialCompletedNCT00044265Phase 4
- CPG 7909 in Patients With Cutaneous T-Cell LymphomaCompletedNCT00043420Phase 1/2
- CPG 7909 in Patients Wih Stage IV Renal Cell CancerCompletedNCT00043407Phase 1/2
- CPG 7909 Plus Herceptin® In Patients With Metastatic Breast CancerCompletedNCT00043394Phase 2
- PF-3512676 (CPG 7909) Injection For Patients Who Completed An Oncology Study Using PF-3512676 (CPG 7909)CompletedNCT00043368Phase 2
- The Safety and Efficacy of Intravenous Anidulafungin as a Treatment for Azole-Refractory Mucosal Candidiasis (FRMC)CompletedNCT00041704Phase 2
- Study Evaluating rhIL-11 in Active Crohn's DiseaseCompletedNCT00040521Phase 2
- Study Evaluating Pantoprazole in Peptic Ulcer HemorrhageCompletedNCT00040495Phase 3
- Open Label, Multicenter, Randomized, Controlled Study of IM or Oral Exemestane (Aromasin) in Postmenopausal WomenTerminatedNCT00040014Phase 2
- Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of ThrombocytopeniaCompletedNCT00039910Phase 3
- Study Evaluating BDDRFVIII and ReFacto AF in Hemophilia ACompletedNCT00038935Phase 3
- Study Evaluating rhIL-11 in Left-Sided Ulcerative ColitisTerminatedNCT00038922Phase 1
- Study Evaluating ReFacto in Hemophilia ACompletedNCT00038909Not applicable
- Study Evaluating Venlafaxine ER in Adults With Panic DisorderCompletedNCT00038896Phase 3
- Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of ThrombocytopeniaCompletedNCT00038311Phase 3
- Irinotecan in Treating Patients With Refractory Solid Tumors and Liver DysfunctionCompletedNCT00037804Phase 1
- Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of ThrombocytopeniaCompletedNCT00037791Phase 3
- Study Evaluating Gemtuzumab Ozogamicin in Acute Myeloid LeukemiaCompletedNCT00037596Phase 2
- Study Evaluating the Safety and Efficacy of Gemtuzumab Ozogamicin in Patients With Acute Myeloid LeukemiaCompletedNCT00037583Phase 2
- Study Evaluating Pantoprazole in Peptic Ulcer HemorrhageCompletedNCT00037570Phase 2
- Study Evaluating rFIX; BeneFIX in Severe Hemophilia BCompletedNCT00037557Phase 3
- Study Evaluating ReFacto AF in Severe Hemophilia ACompletedNCT00037544Phase 3
- Study Evaluating Sirolimus (Rapamune™) in Solid Organ Transplant RecipientsCompletedNCT00037531Phase 3
- The Safety and Effectiveness of Intravenous Anidulafungin as a Treatment for Patients With Invasive Candidiasis.CompletedNCT00037219Phase 2
- A Safety & Effectiveness Study of Intravenous Anidulafungin With AmBisome® for Treatment of Invasive Aspergillosis (IA).CompletedNCT00037206Phase 2/3
- For Prevention of Diarrhea in Patients Diagnosed With Metastatic Colorectal Cancer Treated With ChemotherapyTerminatedNCT00037180Phase 2
- Antibiotic Treatment for Infections of Short Term In-dwelling Vascular Catheters Due to Gram Positive BacteriaCompletedNCT00037050Phase 3
- Chemoprevention of Oral Premalignant LesionsCompletedNCT00036283Phase 2
- Study Evaluating Sumanirole for the Treatment of the Signs and Symptoms of Early Parkinson's Disease.CompletedNCT00036218Phase 3
- Open Label Sumanirole Study of Safety, Tolerability, and Therapeutic Response In Patients With Parkinson's DiseaseTerminatedNCT00036205Phase 3
- Study of the Safety and Efficacy of an Investigational Drug in Adult Patients With Multiple MyelomaCompletedNCT00036140Phase 1
- New Antibiotic to Treat Pediatric Patients With Infections Due to a Specific Bacteria (Vancomycin-Resistant Enterococcus)CompletedNCT00035854Phase 3
- Treatment of Neutropenic Patients With Fever Who Are Suspected to Have A Gram Positive InfectionCompletedNCT00035425Phase 3
- Intravenous Azithromycin Plus Intravenous Ceftriaxone Followed by Oral Azithromycin With Intravenous Levofloxacin Followed by Oral Levofloxacin for the Treatment of Moderate to Severely Ill Hospitalized Patients With Community Acquired PneumoniaCompletedNCT00035347Phase 4